Gsk Plc ADR (GSK)

$51.15 +0.87 (1.73%)
Market Cap 101.70B
Revenue (ttm) 43.08B
Net Income (ttm) 7.54B
EPS (ttm) N/A
PE Ratio 10.40
Forward PE 10.26
Profit Margin 17.50%
Debt to Equity Ratio 1.06
Volume 2,828,900
Avg Vol 4,093,084
Day's Range N/A - N/A
Shares Out 2.02B
Stochastic %K 54%
Beta 0.36
Analysts Sell
Price Target $54.31

Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephr...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 44 20 8047 5000
Website: www.gsk.com
Address:
79 New Oxford Street, London, United Kingdom
IndyOne
IndyOne Aug. 18 at 6:25 PM
$GSK Buyers are present!
0 · Reply
IndyOne
IndyOne Aug. 18 at 6:13 PM
$GSK And away we go? Green go time.
0 · Reply
IndyOne
IndyOne Aug. 18 at 1:55 PM
$GSK Just a matter of time before 51.20 breaks. It's happening.
0 · Reply
IndyOne
IndyOne Aug. 18 at 1:40 PM
$GSK Noice Very
0 · Reply
Quantumup
Quantumup Aug. 18 at 10:28 AM
JPMorgan🏁 $NUVB Overweight-$13 $BMY NUVL - $GSK RHHBY PFE RIGL OTSKY Here's what JPMorgan said in its initiation report: https://x.com/Quantumup1/status/2089660375641813181?s=20
0 · Reply
IndyOne
IndyOne Aug. 17 at 8:02 PM
$GSK Nice close, looks great.
0 · Reply
IndyOne
IndyOne Aug. 17 at 1:40 PM
$GSK Starter position noice. Yes, thinking about adding. Very
0 · Reply
IndyOne
IndyOne Aug. 16 at 1:10 AM
$GSK This one could be good. Have a starter position.
0 · Reply
trendyLuigi
trendyLuigi Aug. 15 at 10:21 PM
$GSK might actually be onto something with this
0 · Reply
Samishere
Samishere Aug. 14 at 3:27 PM
$BNTX $GSK $MRNA $PFE
1 · Reply
Latest News on GSK
Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

Aug 11, 2026, 12:50 PM EDT - 7 days ago

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

GSK MRK

GSK India first-quarter profit rises on steady vaccine demand

Aug 3, 2026, 7:28 AM EDT - 16 days ago

GSK India first-quarter profit rises on steady vaccine demand

GSK

GSK Looks 14.7% Overvalued on GF Value™ as Dividend Sustainability Remains Key

2026-07-31T17:26:00.000Z - 18 days ago

GSK Looks 14.7% Overvalued on GF Value™ as Dividend Sustainability Remains Key

GSK closer to relaunching Brexafemme, says Brookline

2026-07-31T15:50:22.000Z - 18 days ago

GSK closer to relaunching Brexafemme, says Brookline

SCYX

Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals

2026-07-31T14:51:53.000Z - 18 days ago

Weekly Buzz:CIPLA, VTRS Win FDA Nod; BSX Cuts Jobs; ARGX Snaps Up FBRX; JNJ, GSK Strike Deals

Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US

Jul 30, 2026, 4:20 PM EDT - 19 days ago

Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US

COST CVS GSK HLN KVUE PG TGT

GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank

2026-07-30T19:10:26.000Z - 19 days ago

GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank

GSK Strikes $100M AI Deal With Relation Therapeutics To Boost Early Pipeline

2026-07-30T10:58:25.000Z - 20 days ago

GSK Strikes $100M AI Deal With Relation Therapeutics To Boost Early Pipeline

GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal

Jul 30, 2026, 5:15 AM EDT - 20 days ago

GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal

GSK

GSK Looks 19.3% Overvalued on GF Value™ as Dividend Sustainability Faces Mixed Signals

2026-07-29T15:53:02.000Z - 20 days ago

GSK Looks 19.3% Overvalued on GF Value™ as Dividend Sustainability Faces Mixed Signals

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

2026-07-29T14:25:47.000Z - 20 days ago

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

GSK PLC (GSK) Shares Surge 3.3% -- What GF Score of 69 Tells Investors

2026-07-28T22:25:08.000Z - 21 days ago

GSK PLC (GSK) Shares Surge 3.3% -- What GF Score of 69 Tells Investors

GSK set to slash billions in costs over next three years by embracing AI sparking fears of a jobs bloodbath

2026-07-28T21:01:08.000Z - 21 days ago

GSK set to slash billions in costs over next three years by embracing AI sparking fears of a jobs bloodbath

FTSE 100 Advances as Unilever and GSK Results Lift mood

2026-07-28T19:48:23.000Z - 21 days ago

FTSE 100 Advances as Unilever and GSK Results Lift mood

GSK Q2 Earnings Call Highlights

Tue, 28 Jul 2026 14:05:29 -0400 - 21 days ago

GSK Q2 Earnings Call Highlights

GSK Q2 Earnings Call Highlights

2026-07-28T18:04:34.000Z - 21 days ago

GSK Q2 Earnings Call Highlights

GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley

2026-07-28T17:35:21.000Z - 21 days ago

GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley

Earnings tonic boosts FTSE 100 as oil falls back

2026-07-28T16:25:32.000Z - 21 days ago

Earnings tonic boosts FTSE 100 as oil falls back

GSK To Invest £400M In New Flagship R&D Centre In Cambridge, UK

2026-07-28T15:41:15.000Z - 21 days ago

GSK To Invest £400M In New Flagship R&D Centre In Cambridge, UK

GSK Stock Rises as $2.52 Billion Savings Plan Funds Pipeline

2026-07-28T15:13:06.000Z - 21 days ago

GSK Stock Rises as $2.52 Billion Savings Plan Funds Pipeline

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Remains Key

2026-07-28T14:06:44.000Z - 21 days ago

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Remains Key

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Faces Strategic Test

2026-07-28T13:33:57.000Z - 21 days ago

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Faces Strategic Test

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

2026-07-28T13:20:22.000Z - 21 days ago

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

GSK plc Earnings Call Transcript: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 21 days ago

GSK plc Earnings Call Transcript: Q2 2026

GSK plc Quarterly report: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 21 days ago

GSK plc Quarterly report: Q2 2026

GSK plc Slides: Q2 2026

Jul 28, 2026, 9:00 AM EDT - 21 days ago

GSK plc Slides: Q2 2026

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Takes Center Stage

2026-07-28T12:57:39.000Z - 21 days ago

GSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainability Takes Center Stage

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

Jul 28, 2026, 7:47 AM EDT - 22 days ago

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

GSK

GSK sees 70p per share dividend for FY26

2026-07-28T11:41:21.000Z - 22 days ago

GSK sees 70p per share dividend for FY26

GSK initiates ‘Accelerate Growth’ program

2026-07-28T11:40:20.000Z - 22 days ago

GSK initiates ‘Accelerate Growth’ program

GSK reports Q2 core EPS 50.5p, up 9% at CER

2026-07-28T11:36:51.000Z - 22 days ago

GSK reports Q2 core EPS 50.5p, up 9% at CER

GSK beats second-quarter profit estimates, launches $2.52 billion cost savings drive

Jul 28, 2026, 7:09 AM EDT - 22 days ago

GSK beats second-quarter profit estimates, launches $2.52 billion cost savings drive

GSK

GSK to invest £400 million in Britain over 3 years as it ramps up R&D efforts

Jul 28, 2026, 7:03 AM EDT - 22 days ago

GSK to invest £400 million in Britain over 3 years as it ramps up R&D efforts

GSK

GSK to shut Stevenage R&D hub under plans to open new site in Cambridge

2026-07-28T11:00:00.000Z - 22 days ago

GSK to shut Stevenage R&D hub under plans to open new site in Cambridge

GSK, Hansoh's cancer drug meets main goal of bone cancer trial

Jul 28, 2026, 6:17 AM EDT - 22 days ago

GSK, Hansoh's cancer drug meets main goal of bone cancer trial

GSK

AI sell-off deepens as chip stocks slump in market retreat - business live

2026-07-28T06:31:29.000Z - 22 days ago

AI sell-off deepens as chip stocks slump in market retreat - business live

GSK Looks 17.5% Overvalued on GF Value™ as Dividend Sustainability Comes into Focus

2026-07-27T19:01:42.000Z - 22 days ago

GSK Looks 17.5% Overvalued on GF Value™ as Dividend Sustainability Comes into Focus

GSK Looks 17.4% Overvalued on GF Value™ as Dividend Sustainability Remains a Key Focus

2026-07-27T18:25:34.000Z - 22 days ago

GSK Looks 17.4% Overvalued on GF Value™ as Dividend Sustainability Remains a Key Focus

GSK Looks 18.3% Overvalued on GF Value™ as Q2 Earnings Forecasts a Sharp EPS Drop

2026-07-27T16:55:38.000Z - 22 days ago

GSK Looks 18.3% Overvalued on GF Value™ as Q2 Earnings Forecasts a Sharp EPS Drop

Earnings To Watch: GSK PLC (LSE:GSK) Reports Q2 2026 Result

2026-07-27T13:17:00.000Z - 22 days ago

Earnings To Watch: GSK PLC (LSE:GSK) Reports Q2 2026 Result

Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

2026-07-24T15:02:33.000Z - 25 days ago

Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

GSK Reinstated by Citigroup -- Rating Set to Neutral

2026-07-24T12:30:57.000Z - 25 days ago

GSK Reinstated by Citigroup -- Rating Set to Neutral

GSK Receives Approval for Shingrix Prefilled Syringe

2026-07-24T12:25:27.000Z - 25 days ago

GSK Receives Approval for Shingrix Prefilled Syringe

GSK Canada announces approval of Shingrix in prefilled syringe

2026-07-24T11:00:38.000Z - 26 days ago

GSK Canada announces approval of Shingrix in prefilled syringe

GSK Receives Neutral Rating from Citi with 2,100 GBp Price Target

2026-07-24T09:50:53.000Z - 26 days ago

GSK Receives Neutral Rating from Citi with 2,100 GBp Price Target

GSK resumed with a Neutral at Citi

2026-07-24T08:20:10.000Z - 26 days ago

GSK resumed with a Neutral at Citi

AstraZeneca 'magic' faces rare test after trial failure, share slide

2026-07-24T06:16:46.185Z - 26 days ago

AstraZeneca 'magic' faces rare test after trial failure, share slide

GSK Wins Early FDA Approval For Jideytro In ROS1-Positive Lung Cancer For Adults

2026-07-23T05:26:21.000Z - 27 days ago

GSK Wins Early FDA Approval For Jideytro In ROS1-Positive Lung Cancer For Adults

GSK Enters Lung Cancer Therapy Market with FDA Approval of Jideytro

2026-07-22T19:56:15.000Z - 27 days ago

GSK Enters Lung Cancer Therapy Market with FDA Approval of Jideytro

GSK Receives FDA Approval for Jideytro to Treat ROS1-Positive Lung Cancer

2026-07-22T18:26:03.000Z - 27 days ago

GSK Receives FDA Approval for Jideytro to Treat ROS1-Positive Lung Cancer

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Jul 22, 2026, 1:58 PM EDT - 27 days ago

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

GSK

GSK reports Jideytro approved by FDA for ROS1-positive NSCLC

2026-07-22T16:45:26.000Z - 27 days ago

GSK reports Jideytro approved by FDA for ROS1-positive NSCLC

US FDA approves GSK's lung cancer drug

Jul 22, 2026, 12:31 PM EDT - 27 days ago

US FDA approves GSK's lung cancer drug

GSK

ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

Jul 21, 2026, 4:00 AM EDT - 4 weeks ago

ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

Jul 17, 2026, 9:13 AM EDT - 4 weeks ago

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

GSK to halt further development of cough drug after missing main goal

Jul 17, 2026, 4:42 AM EDT - 4 weeks ago

GSK to halt further development of cough drug after missing main goal

GSK's Jemperli meets main goal in mid-stage rectal cancer trial

Jul 13, 2026, 3:15 AM EDT - 5 weeks ago

GSK's Jemperli meets main goal in mid-stage rectal cancer trial

GSK's targeted cancer therapy shows positive results in late-stage study

Jul 10, 2026, 7:38 AM EDT - 5 weeks ago

GSK's targeted cancer therapy shows positive results in late-stage study

Alector and GSK partnership to end after dementia, Alzheimer's drug failures

Jul 8, 2026, 5:20 PM EDT - 5 weeks ago

Alector and GSK partnership to end after dementia, Alzheimer's drug failures

ALEC

Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs

Jul 8, 2026, 12:52 AM EDT - 6 weeks ago

Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Jun 17, 2026, 4:21 PM EDT - 2 months ago

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

SPRO

US FDA approves GSK's oral antibiotic for drug-resistant UTIs

Jun 17, 2026, 11:11 AM EDT - 2 months ago

US FDA approves GSK's oral antibiotic for drug-resistant UTIs

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

Jun 16, 2026, 1:00 AM EDT - 2 months ago

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC

ARKG IBB XBI NUVL NVS

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Jun 11, 2026, 2:04 AM EDT - 2 months ago

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

NUVL

After shedding its cancer business just over a decade ago, GSK's new CEO is building back with a $10.6 billion deal

Jun 9, 2026, 9:00 PM EDT - 2 months ago

After shedding its cancer business just over a decade ago, GSK's new CEO is building back with a $10.6 billion deal

NUVL

Tuesday's Morning Movers: MU Rebounds, ON PT Increases & GSK Buys NUVL

Jun 9, 2026, 10:30 AM EDT - 2 months ago

Tuesday's Morning Movers: MU Rebounds, ON PT Increases & GSK Buys NUVL

MU NUVL ON

GSK's $10.6B Nuvalent takeover fails to impress investors as shares fall: here's why

Jun 9, 2026, 7:02 AM EDT - 2 months ago

GSK's $10.6B Nuvalent takeover fails to impress investors as shares fall: here's why

NUVL

Cancer-Drug Stock Jumps 39% on $10.6 Billion GSK Deal. Why It's a Surprise Move.

Jun 9, 2026, 5:56 AM EDT - 2 months ago

Cancer-Drug Stock Jumps 39% on $10.6 Billion GSK Deal. Why It's a Surprise Move.

NUVL

London's FTSE 100 falls as GSK slides after Nuvalent deal

Jun 9, 2026, 5:13 AM EDT - 2 months ago

London's FTSE 100 falls as GSK slides after Nuvalent deal

NUVL

GSK plc Transcript: M&A announcement

Jun 9, 2026, 4:00 AM EDT - 2 months ago

GSK plc Transcript: M&A announcement

GSK plc Slides: M&A announcement

Jun 9, 2026, 4:00 AM EDT - 2 months ago

GSK plc Slides: M&A announcement

GSK plc Press release: M&A announcement

Jun 9, 2026, 4:00 AM EDT - 2 months ago

GSK plc Press release: M&A announcement

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Jun 9, 2026, 3:37 AM EDT - 2 months ago

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

NUVL

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

Jun 9, 2026, 2:29 AM EDT - 2 months ago

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

NUVL

UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion

Jun 9, 2026, 2:04 AM EDT - 2 months ago

UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion

NUVL

GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT

Jun 9, 2026, 12:31 AM EDT - 2 months ago

GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT

NUVL

GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports

Jun 8, 2026, 9:15 PM EDT - 2 months ago

GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports

NUVL

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

Jun 8, 2026, 6:16 AM EDT - 2 months ago

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

GSK plc Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 11:40 AM EDT - 2 months ago

GSK plc Transcript: Jefferies Global Healthcare Conference 2026

GSK plc Transcript: Study update

May 28, 2026, 10:00 AM EDT - 2 months ago

GSK plc Transcript: Study update

GSK plc Slides: Study update

May 28, 2026, 10:00 AM EDT - 2 months ago

GSK plc Slides: Study update

GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials

May 28, 2026, 4:56 AM EDT - 2 months ago

GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

May 28, 2026, 4:31 AM EDT - 2 months ago

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK to team up with Sino Biopharma for China launch of hepatitis B treatment

May 11, 2026, 2:28 AM EDT - 3 months ago

GSK to team up with Sino Biopharma for China launch of hepatitis B treatment

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

May 7, 2026, 8:00 AM EDT - 3 months ago

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

Big Pharma M&A set for mega year as patent expiries drive deal urgency

May 1, 2026, 10:03 AM EDT - 3 months ago

Big Pharma M&A set for mega year as patent expiries drive deal urgency

ABBV BMY GILD LLY

GSK plc Earnings Call Transcript: Q1 2026

Apr 29, 2026, 7:00 AM EDT - 4 months ago

GSK plc Earnings Call Transcript: Q1 2026

GSK plc Quarterly report: Q1 2026

Apr 29, 2026, 7:00 AM EDT - 4 months ago

GSK plc Quarterly report: Q1 2026

GSK plc Slides: Q1 2026

Apr 29, 2026, 7:00 AM EDT - 4 months ago

GSK plc Slides: Q1 2026

UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies

Apr 29, 2026, 5:32 AM EDT - 4 months ago

UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies

NVS

GSK Earnings Boosted by Higher Specialty Medicine Sales

Apr 29, 2026, 2:45 AM EDT - 4 months ago

GSK Earnings Boosted by Higher Specialty Medicine Sales

GSK beats quarterly profit estimates on strength in respiratory, general medicines

Apr 29, 2026, 2:06 AM EDT - 4 months ago

GSK beats quarterly profit estimates on strength in respiratory, general medicines

Top FTSE 100 shares to watch next week: Lloyds, Barclays, GSK, Natwest

Apr 24, 2026, 3:28 AM EDT - 4 months ago

Top FTSE 100 shares to watch next week: Lloyds, Barclays, GSK, Natwest

BCS LYG NWG

FTSE 100 Index retreats ahead of Lloyds, Barclays, Natwest, GSK earnings

Apr 23, 2026, 5:50 AM EDT - 4 months ago

FTSE 100 Index retreats ahead of Lloyds, Barclays, Natwest, GSK earnings

BCS LYG NWG

GSK sees blockbuster potential in targeted cancer therapy after promising early data

Apr 12, 2026, 10:12 AM EDT - 4 months ago

GSK sees blockbuster potential in targeted cancer therapy after promising early data

GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug's label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.

Apr 9, 2026, 3:07 PM EDT - 4 months ago

GSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug's label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Mar 31, 2026, 10:00 AM EDT - 5 months ago

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 5 months ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

LLY NVO PFE PPH

GSK plc Transcript: Goldman Sachs 9th Annual Biopharma Innovation Summit

Mar 26, 2026, 5:00 AM EDT - 5 months ago

GSK plc Transcript: Goldman Sachs 9th Annual Biopharma Innovation Summit

US FDA approves GSK's drug for liver disease related itching

Mar 19, 2026, 8:08 AM EDT - 5 months ago

US FDA approves GSK's drug for liver disease related itching

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 5 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD JNJ LLY

GSK and Amgen to add medicines to TrumpRx, Fox Business reports

Mar 13, 2026, 8:27 PM EDT - 5 months ago

GSK and Amgen to add medicines to TrumpRx, Fox Business reports

AMGN

IndyOne
IndyOne Aug. 18 at 6:25 PM
$GSK Buyers are present!
0 · Reply
IndyOne
IndyOne Aug. 18 at 6:13 PM
$GSK And away we go? Green go time.
0 · Reply
IndyOne
IndyOne Aug. 18 at 1:55 PM
$GSK Just a matter of time before 51.20 breaks. It's happening.
0 · Reply
IndyOne
IndyOne Aug. 18 at 1:40 PM
$GSK Noice Very
0 · Reply
Quantumup
Quantumup Aug. 18 at 10:28 AM
JPMorgan🏁 $NUVB Overweight-$13 $BMY NUVL - $GSK RHHBY PFE RIGL OTSKY Here's what JPMorgan said in its initiation report: https://x.com/Quantumup1/status/2089660375641813181?s=20
0 · Reply
IndyOne
IndyOne Aug. 17 at 8:02 PM
$GSK Nice close, looks great.
0 · Reply
IndyOne
IndyOne Aug. 17 at 1:40 PM
$GSK Starter position noice. Yes, thinking about adding. Very
0 · Reply
IndyOne
IndyOne Aug. 16 at 1:10 AM
$GSK This one could be good. Have a starter position.
0 · Reply
trendyLuigi
trendyLuigi Aug. 15 at 10:21 PM
$GSK might actually be onto something with this
0 · Reply
Samishere
Samishere Aug. 14 at 3:27 PM
$BNTX $GSK $MRNA $PFE
1 · Reply
TaxLossMaster
TaxLossMaster Aug. 14 at 11:51 AM
$GSK horrible stock. Bleeding me
1 · Reply
La_Parka3
La_Parka3 Aug. 14 at 10:26 AM
$MRNA $PFE $GSK $SNY An anti vaxxer doing his research:
2 · Reply
Samishere
Samishere Aug. 13 at 11:15 PM
$BNTX $GSK $MRNA $PFE
0 · Reply
Samishere
Samishere Aug. 13 at 7:38 PM
$BNTX $GSK $MRNA $PFE
0 · Reply
La_Parka3
La_Parka3 Aug. 13 at 2:14 PM
$MRNA $PFE $BNTX $GSK Bygone 2021 vaccine mandates vs. shorts who thought removing the mandates would eliminate demand and bankrupt vaccine companies:
0 · Reply
La_Parka3
La_Parka3 Aug. 13 at 9:19 AM
$MRNA $PFE $BNTX $GSK Reading the antivaccine comments here is like reading Yelp reviews of steakhouses written by vegetarians. They’re interesting, sometimes funny, but ultimately useless because they don’t even know what meat tastes like.
1 · Reply
IndyOne
IndyOne Aug. 12 at 7:56 PM
$GSK Action looked good today, gonna try to buy the dip now. Probably not gonna keep it hooked.
1 · Reply
IndyOne
IndyOne Aug. 12 at 3:51 PM
$GSK Dead cat bounce. $49.XX by close.
0 · Reply
La_Parka3
La_Parka3 Aug. 12 at 3:53 AM
$MRNA $PFE $GSK $MRK The real damage crazy antivaxxers are inflicting is discredit the real extremely rare cases where victims genuinely deserve compensation from a vaccine administration.
0 · Reply
Matt_1
Matt_1 Aug. 11 at 2:32 PM
$CVRX $GSK $JNJ 👍
0 · Reply
Pissed_of_retards2
Pissed_of_retards2 Aug. 11 at 10:08 AM
$NVAX $GSK this is a chance for GSK be on the market sooner than pfizer and sanofi? basically be second or together with moderna? and pfizer is the big player of market
0 · Reply
Pissed_of_retards2
Pissed_of_retards2 Aug. 11 at 9:59 AM
$NVAX $GSK combo vaccine phase 1 will be completed next year. i understand they are proud of own product and love mRNA but they prefer to be late to the market instead of finishing next year novavax phase 3b and be among first movers?
2 · Reply